Cargando…
P1617: A PHASE 1 STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF A PEGYLATED-RECOMBINANT HUMAN COAGULATION FACTOR VIII-FC FUSION PROTEIN WITH HALF-LIFE IN PATIENTS WITH SEVERE HEMOPHILIA A
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430368/ http://dx.doi.org/10.1097/01.HS9.0000973344.66414.ba |
| _version_ | 1785090946458714112 |
|---|---|
| author | Xue, Feng Chen, Yun Chen Sun, Jing Guo, Shuxia Wen, Qing Xu, Chongyuan Yang, Renchi |
| author_facet | Xue, Feng Chen, Yun Chen Sun, Jing Guo, Shuxia Wen, Qing Xu, Chongyuan Yang, Renchi |
| author_sort | Xue, Feng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430368 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104303682023-08-17 P1617: A PHASE 1 STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF A PEGYLATED-RECOMBINANT HUMAN COAGULATION FACTOR VIII-FC FUSION PROTEIN WITH HALF-LIFE IN PATIENTS WITH SEVERE HEMOPHILIA A Xue, Feng Chen, Yun Chen Sun, Jing Guo, Shuxia Wen, Qing Xu, Chongyuan Yang, Renchi Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430368/ http://dx.doi.org/10.1097/01.HS9.0000973344.66414.ba Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Xue, Feng Chen, Yun Chen Sun, Jing Guo, Shuxia Wen, Qing Xu, Chongyuan Yang, Renchi P1617: A PHASE 1 STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF A PEGYLATED-RECOMBINANT HUMAN COAGULATION FACTOR VIII-FC FUSION PROTEIN WITH HALF-LIFE IN PATIENTS WITH SEVERE HEMOPHILIA A |
| title | P1617: A PHASE 1 STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF A PEGYLATED-RECOMBINANT HUMAN COAGULATION FACTOR VIII-FC FUSION PROTEIN WITH HALF-LIFE IN PATIENTS WITH SEVERE HEMOPHILIA A |
| title_full | P1617: A PHASE 1 STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF A PEGYLATED-RECOMBINANT HUMAN COAGULATION FACTOR VIII-FC FUSION PROTEIN WITH HALF-LIFE IN PATIENTS WITH SEVERE HEMOPHILIA A |
| title_fullStr | P1617: A PHASE 1 STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF A PEGYLATED-RECOMBINANT HUMAN COAGULATION FACTOR VIII-FC FUSION PROTEIN WITH HALF-LIFE IN PATIENTS WITH SEVERE HEMOPHILIA A |
| title_full_unstemmed | P1617: A PHASE 1 STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF A PEGYLATED-RECOMBINANT HUMAN COAGULATION FACTOR VIII-FC FUSION PROTEIN WITH HALF-LIFE IN PATIENTS WITH SEVERE HEMOPHILIA A |
| title_short | P1617: A PHASE 1 STUDY TO EVALUATE THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF A PEGYLATED-RECOMBINANT HUMAN COAGULATION FACTOR VIII-FC FUSION PROTEIN WITH HALF-LIFE IN PATIENTS WITH SEVERE HEMOPHILIA A |
| title_sort | p1617: a phase 1 study to evaluate the pharmacokinetics, safety and tolerability of a pegylated-recombinant human coagulation factor viii-fc fusion protein with half-life in patients with severe hemophilia a |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430368/ http://dx.doi.org/10.1097/01.HS9.0000973344.66414.ba |
| work_keys_str_mv | AT xuefeng p1617aphase1studytoevaluatethepharmacokineticssafetyandtolerabilityofapegylatedrecombinanthumancoagulationfactorviiifcfusionproteinwithhalflifeinpatientswithseverehemophiliaa AT chenyunchen p1617aphase1studytoevaluatethepharmacokineticssafetyandtolerabilityofapegylatedrecombinanthumancoagulationfactorviiifcfusionproteinwithhalflifeinpatientswithseverehemophiliaa AT sunjing p1617aphase1studytoevaluatethepharmacokineticssafetyandtolerabilityofapegylatedrecombinanthumancoagulationfactorviiifcfusionproteinwithhalflifeinpatientswithseverehemophiliaa AT guoshuxia p1617aphase1studytoevaluatethepharmacokineticssafetyandtolerabilityofapegylatedrecombinanthumancoagulationfactorviiifcfusionproteinwithhalflifeinpatientswithseverehemophiliaa AT wenqing p1617aphase1studytoevaluatethepharmacokineticssafetyandtolerabilityofapegylatedrecombinanthumancoagulationfactorviiifcfusionproteinwithhalflifeinpatientswithseverehemophiliaa AT xuchongyuan p1617aphase1studytoevaluatethepharmacokineticssafetyandtolerabilityofapegylatedrecombinanthumancoagulationfactorviiifcfusionproteinwithhalflifeinpatientswithseverehemophiliaa AT yangrenchi p1617aphase1studytoevaluatethepharmacokineticssafetyandtolerabilityofapegylatedrecombinanthumancoagulationfactorviiifcfusionproteinwithhalflifeinpatientswithseverehemophiliaa |